New Drug Approvals Archive - September 2005
ProQuad (measles, mumps, rubella and varicella virus vaccine, live) Injection
Date of Approval: September 6, 2005
Company: Merck & Co., Inc.
Treatment for: Mumps Prophylaxis, Measles Prophylaxis, Rubella Prophylaxis, Varicella-Zoster -- Prophylaxis
ProQuad (measles, mumps, rubella and varicella virus vaccine, live) is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.
Angeliq (drospirenone and estradiol) Tablets
Date of Approval: September 28, 2005
Company: Berlex, Inc.
Treatment for: Postmenopausal Symptoms
Angeliq is a hormone replacement therapy containing estradiol and the progestin drospirenone, a hormone that counters the excess water and sodium buildup that is a side effect of estradiol. Angeliq is used to treat moderate to severe menopausal symptoms, such as hot flashes and vaginal dryness.
Angeliq (drospirenone and estradiol)
New Formulation Approved: February 29, 2012